Lawrence G. Hamel, Chief Development Officer at ACELRX PHARMACEUTICALS INC (ACRX), sold 20,322 shares at $5.29 ($108K) on 2017-10-02, disclosed to the SEC on 2017-10-03.
Open-market sale of $108k ACRX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.29 | 10,161 | $54K | 50.0% |
| 2 | $5.29 | 10,161 | $54K | 50.0% |
| Total | $5.29 avg | 20,322 | $108K | 100% |
| Filing → |
| ACRX | SELL | 2018-09-26 | $31K | — | Filing → |